Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG: 1349)

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Market Cap

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. has a market cap or net worth of 5.75 billion as of September 9, 2024. Its market cap has decreased by -30.72% in one year.

• Market Cap: 5.75B
• Enterprise Value: 4.45B
• Revenue: 790.86M
• Ranking: n/a
• PE Ratio: 15.17
• Stock Price: 1.79

Market Cap Chart

Since August 13, 2002, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.'s market cap has increased from 582.40M to 5.75B, an increase of 886.81%. That is a compound annual growth rate of 10.93%.

Market Cap History

Date	Market Cap	% Change
Sep 5, 2024	5.85B	-27.42%
Dec 29, 2023	8.06B	3.73%
Dec 30, 2022	7.77B	-42.18%
Dec 31, 2021	13.43B	-14.60%
Dec 31, 2020	15.73B	282.12%
Dec 31, 2019	4.12B	14.07%